In contrast, CTSE overexpression has been suggested to promote gastric cancer [8], pancreatic ductal adenocarcinoma [9], cervical adenocarcinoma [10], and lung carcinoma [11] development. The gene discussed is CTSE; the disease is gastric cancer.